ONTELRIQ
DEAD

Serial Number

79337831

Owner

IPSEN PHARMA S.A.S.

Attorney

Ben Natter

Filing Date

Feb 16, 2022

Add to watchlist:

No watchlists yet
View on USPTO

ONTELRIQ Trademark

Serial Number: 79337831

ONTELRIQ is a trademark filed by IPSEN PHARMA S.A.S. on February 16, 2022. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently no longer active.

Owner Contact Info

IPSEN PHARMA S.A.S. (154 trademarks)

65 QUAI GEORGES GORSE
BOULOGNE-BILLANCOURT 92100 , FR

Entity Type: 11

Trademark Details

Filing Date

February 16, 2022

Registration Date

Not Registered

Published for Opposition

September 26, 2023

Filing History

NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED
Nov 21, 2023 DENA
DEATH OF INTERNATIONAL REGISTRATION
Nov 20, 2023 DETH
NOTIFICATION PROCESSED BY IB
Oct 31, 2023 GPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Oct 3, 2023 OPNX
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Sep 26, 2023 NPUB
PUBLISHED FOR OPPOSITION
Sep 26, 2023 PUBO
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Sep 13, 2023 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Sep 13, 2023 OPNR
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Sep 6, 2023 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Sep 6, 2023 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Sep 6, 2023 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Aug 22, 2023 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jul 19, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 19, 2023 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jul 19, 2023 TROA
REFUSAL PROCESSED BY IB
Feb 27, 2023 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Jan 27, 2023 RFCS
REFUSAL PROCESSED BY MPU
Jan 27, 2023 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Dec 10, 2022 RFCR
NON-FINAL ACTION WRITTEN
Dec 9, 2022 CNRT
ASSIGNED TO EXAMINER
Dec 1, 2022 DOCK
APPLICATION FILING RECEIPT MAILED
Apr 12, 2022 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Apr 8, 2022 NWOS
SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB
Apr 7, 2022 SDRC